Clinical Trials on Reduced Ventricular Ejection Fraction in Japan
Total 17 results
-
Bristol-Myers SquibbCompletedHeart Failure | Cardiac Failure | Reduced Ventricular Ejection FractionUnited States, United Kingdom, Japan, Netherlands
-
Eli Lilly and CompanyCompletedChronic Heart Failure With Reduced Ejection FractionUnited States, Japan
-
CytokineticsCompletedHeart Failure With Reduced Ejection FractionJapan
-
AstraZenecaCompletedHeart Failure With Reduced Ejection Fraction (HFrEF)United States, Canada, Denmark, Korea, Republic of, Brazil, Slovakia, Japan, South Africa, Sweden
-
Novartis PharmaceuticalsCompletedHeart Failure With Reduced Ejection Fraction (HF-rEF)Japan
-
AstraZenecaCompletedChronic Heart Failure With Reduced Ejection Fraction (HFrEF)United States, Canada, Denmark, United Kingdom, Czechia, Vietnam, Germany, Brazil, India, China, Japan, Taiwan, Netherlands, Bulgaria, Slovakia, Hungary, Poland, Russian Federation, Argentina, Sweden
-
Novartis PharmaceuticalsTerminatedHeart Failure With Preserved Ejection Fraction (HFpEF)Japan
-
AstraZenecaCompletedHeart Failure With Preserved Ejection FractionUnited States, France, Netherlands, Belgium, Taiwan, Slovakia, Japan, Czechia, Hungary, Australia, Bulgaria, Poland, Russian Federation, Brazil, Denmark, Turkey, Sweden, Canada
-
AstraZenecaCompletedHeart Failure With Preserved Ejection Fraction (HFpEF)United States, Denmark, Italy, Canada, Korea, Republic of, Brazil, Slovakia, Japan, Bulgaria, South Africa, Sweden, Argentina
-
Novartis PharmaceuticalsCompletedHeart Failure With Preserved Ejection FractionChina, Germany, United States, Colombia, South Africa, Italy, Austria, Belgium, Croatia, Romania, Taiwan, Japan, Netherlands, Denmark, France, Israel, Spain, Switzerland, Korea, Republic of, Argentina, Canada, United Kingdom, Bulgaria, Gree... and more
-
Eli Lilly and CompanyRecruitingHeart Failure | Heart Failure With Preserved Ejection FractionSpain, United States, Japan, United Kingdom, Czechia, Hungary, Israel, Brazil, Argentina, Canada, Poland, Turkey
-
BayerMerck Sharp & Dohme LLC; Duke Clinical Research Institute; Canadian VIGOUR CentreCompletedChronic Heart Failure With Preserved Ejection FractionSpain, United States, Belgium, Singapore, Taiwan, Canada, Japan, Italy, Austria, Bulgaria, Germany, Greece, Israel, Poland, Portugal, Hungary, Russian Federation, Argentina, Colombia, Malaysia, South Africa
-
AstraZenecaCompletedHeart Failure With Preserved Ejection FractionUnited States, Canada, Belgium, Czechia, Hungary, Taiwan, Vietnam, Mexico, Peru, China, Japan, Bulgaria, Spain, Brazil, Saudi Arabia, Netherlands, Romania, Russian Federation, Poland, Argentina
-
Medtronic Bakken Research CenterMedtronic; Medtronic Japan Co., Ltd.CompletedHeart Failure | Left Bundle-Branch Block | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IV | Heart Failure With Reduced Ejection Fraction (HFrEF)Korea, Republic of, Japan, Singapore, Taiwan, Hong Kong, Indonesia, Malaysia, China, Philippines, Brunei Darussalam
-
PfizerTerminatedHeart Failure With Preserved Ejection Fraction | Transthyretin Amyloid CardiomyopathySpain, United States, Japan, Canada, France, Italy, Poland, United Kingdom
-
Andreas Benesic, MDMetaHeps GmbHUnknownAdverse Reaction to Drug | Drug-induced Disorder of LiverHong Kong, Australia, Germany, Japan, Korea, Republic of
-
Novo Nordisk A/SCompletedHeart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2United States, Spain, Hungary, United Kingdom, India, Netherlands, Germany, Japan, Canada, Czechia, Argentina, Austria, Israel, Italy, Poland, Sweden